BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williamson SR, Taneja K, Cheng L. Renal cell carcinoma staging: pitfalls, challenges, and updates. Histopathology. 2019;74:18-30. [PMID: 30565307 DOI: 10.1111/his.13743] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Ficarra V, Caloggero S, Rossanese M, Giannarini G, Crestani A, Ascenti G, Novara G, Porpiglia F. Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy. Minerva Urol Nephrol 2021;73:17-31. [PMID: 33200903 DOI: 10.23736/S2724-6051.20.04073-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Akgul M, Cheng L. Immunophenotypic and pathologic heterogeneity of unclassified renal cell carcinoma: a study of 300 cases. Hum Pathol 2020;102:70-8. [PMID: 32619439 DOI: 10.1016/j.humpath.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Favi E, Raison N, Ambrogi F, Delbue S, Clementi MC, Lamperti L, Perego M, Bischeri M, Ferraresso M. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. World J Clin Cases 2019; 7(17): 2487-2504 [PMID: 31559284 DOI: 10.12998/wjcc.v7.i17.2487] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
4 Mollica V, Rizzo A, Di Nunno V, Santoni M, Cheng L, Lopez-Beltran A, Scarpelli M, Cimadamore A, Montironi R, Massari F. Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF? Transl Androl Urol 2021;10:1581-7. [PMID: 33850792 DOI: 10.21037/tau-20-1125] [Reference Citation Analysis]
5 Hashmi F, Mollapour M, Bratslavsky G, Bourboulia D. MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer. Urol Oncol 2021;39:316-21. [PMID: 32487351 DOI: 10.1016/j.urolonc.2020.04.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sebastià C, Corominas D, Musquera M, Paño B, Ajami T, Nicolau C. Active surveillance of small renal masses. Insights Imaging 2020;11:63. [PMID: 32372194 DOI: 10.1186/s13244-020-00853-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 2021;34:1392-424. [PMID: 33664427 DOI: 10.1038/s41379-021-00779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
8 Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol 2021;107:46-57. [PMID: 33166576 DOI: 10.1016/j.humpath.2020.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mo X, Zhou M, Yan H, Chen X, Wang Y. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis. BMC Cancer 2021;21:13. [PMID: 33402111 DOI: 10.1186/s12885-020-07718-z] [Reference Citation Analysis]
10 Guo H, Zhao W, Wang A, Li M, Ma H, Wang F, Wang Q, Ba X. The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage. Adipocyte 2021;10:285-92. [PMID: 34014795 DOI: 10.1080/21623945.2021.1924957] [Reference Citation Analysis]
11 MacLennan GT, Cheng L. Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. Hum Pathol 2020;95:24-45. [PMID: 31655169 DOI: 10.1016/j.humpath.2019.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
12 Zarrabi K, Paroya A, Wu S. Emerging therapeutic agents for genitourinary cancers. J Hematol Oncol 2019;12:89. [PMID: 31484560 DOI: 10.1186/s13045-019-0780-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
13 Mignano SE, Russell DH. Nodular Vascular Transformation of the Lymph Node Sinuses Mimicking Sarcomatoid Change in Renal Cell Carcinoma: A Potential Diagnostic Pitfall. Int J Surg Pathol 2020;28:637-42. [PMID: 32390486 DOI: 10.1177/1066896920916243] [Reference Citation Analysis]
14 Valencia-Guerrero A, Oliva E, Wu CL, Wu S, Rice-Stitt T, Sadow PM, Dahl DM, Feldman AS, Arellano RS, Cornejo KM. To stage or not to stage: determining the true clinical significance of the biopsy tract through perinephric fat in assessing renal cell carcinoma. Histopathology 2021;78:951-62. [PMID: 33236381 DOI: 10.1111/his.14309] [Reference Citation Analysis]
15 Elkassem AA, Allen BC, Sharbidre KG, Rais-Bahrami S, Smith AD. Update on the Role of Imaging in Clinical Staging and Restaging of Renal Cell Carcinoma Based on the AJCC 8th Edition, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol 2021;217:541-55. [PMID: 33759558 DOI: 10.2214/AJR.21.25493] [Reference Citation Analysis]
16 Lee HW, Cho HH, Joung JG, Jeon HG, Jeong BC, Jeon SS, Lee HM, Nam DH, Park WY, Kim CK, Seo SI, Park H. Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study. Cancers (Basel) 2020;12:E866. [PMID: 32252440 DOI: 10.3390/cancers12040866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kubiliūtė R, Žukauskaitė K, Žalimas A, Ulys A, Sabaliauskaitė R, Bakavičius A, Želvys A, Jankevičius F, Jarmalaitė S. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma. J Cancer Res Clin Oncol 2021. [PMID: 34689221 DOI: 10.1007/s00432-021-03837-7] [Reference Citation Analysis]
18 Brossa A, Fonsato V, Grange C, Tritta S, Tapparo M, Calvetti R, Cedrino M, Fallo S, Gontero P, Camussi G, Bussolati B. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Int J Cancer 2020;147:1694-706. [PMID: 32064610 DOI: 10.1002/ijc.32925] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
19 Canete-Portillo S, Rodriguez Pena MDC, Wang D, Sanchez DF, Netto GJ, Magi-Galluzzi C. Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma. Virchows Arch 2021. [PMID: 34611731 DOI: 10.1007/s00428-021-03214-2] [Reference Citation Analysis]
20 Tian M, Wang T, Wang P. Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer. Cell Transplant 2021;30:963689720969176. [PMID: 33626918 DOI: 10.1177/0963689720969176] [Reference Citation Analysis]
21 Zhao H, Li W, Le X, Li Z, Ge P. Preoperative Neutrophil-to-Lymphocyte Ratio Was a Predictor of Overall Survival in Small Renal Cell Carcinoma: An Analysis of 384 Consecutive Patients. Biomed Res Int 2020;2020:8051210. [PMID: 32219142 DOI: 10.1155/2020/8051210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Osmanov YI, Kogan EA, Radenska-Lopovok SG. [The morphological characteristics and immunophenotype of renal cell carcinomas with eosinophilic cytoplasm]. Arkh Patol 2020;82:20-9. [PMID: 32307435 DOI: 10.17116/patol20208202120] [Reference Citation Analysis]
23 Delahunt B, Eble JN, Samaratunga H, Thunders M, Yaxley JW, Egevad L. Staging of renal cell carcinoma: current progress and potential advances. Pathology 2021;53:120-8. [PMID: 33121821 DOI: 10.1016/j.pathol.2020.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wang H, Chong T, Li BY, Chen XS, Zhen WB. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer. Biol Res 2020;53:46. [PMID: 33066813 DOI: 10.1186/s40659-020-00314-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Zhu W, Jiang H, Xie S, Xiao H, Liu Q, Chen N, Wan P, Lu S. Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma. PeerJ 2021;9:e12086. [PMID: 34567842 DOI: 10.7717/peerj.12086] [Reference Citation Analysis]
26 Liu N, Qu F, Shi Q, Zhuang W, Ma W, Yang Z, Sun J, Xu W, Zhang L, Jia R, Xu L, Zhao X, Li X, Zhang G, Guo H, Li D, Gan W. Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China. Ann Surg Oncol 2021;28:1238-46. [PMID: 32632879 DOI: 10.1245/s10434-020-08813-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Grange C, Brossa A, Bussolati B. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma. Int J Mol Sci 2019;20:E1832. [PMID: 31013896 DOI: 10.3390/ijms20081832] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
28 Algaba F. [Criteria for an improved prognostic stratification in category pT renal carcinoma]. Rev Esp Patol 2021;54:171-81. [PMID: 34175029 DOI: 10.1016/j.patol.2020.09.004] [Reference Citation Analysis]